1. Researchers at Chiba University, Japan, have developed a nasal vaccine for cervical cancer using a substance derived from the human papillomavirus.
2. The vaccine induces immune cells to attack cervical cancer cells, and it was successful in destroying cancer cells in mice tests and inducing immune cells at the cervix in monkey tests.
3. The researchers aim to test the vaccine's effectiveness on humans, hoping to provide a new method of treatment that doesn't require surgery or radiation therapy.
2. The vaccine induces immune cells to attack cervical cancer cells, and it was successful in destroying cancer cells in mice tests and inducing immune cells at the cervix in monkey tests.
3. The researchers aim to test the vaccine's effectiveness on humans, hoping to provide a new method of treatment that doesn't require surgery or radiation therapy.
Similar Readings (5 items)
Japanese group uses immune cell-inducing vaccine to remove cervical cancer cells
University of Tokyo building facility for clinical vaccine trials
Novavax approved in Japan, expected to be available in late May
Tests show Omicron vaccines 71% effective in preventing infection
Japanese researchers say they produced hair shafts in lab
Summary
Researchers at Chiba University, Japan, developed a nasal vaccine for cervical cancer using human papillomavirus derivative. Vaccine induces immune cells to attack cervical cancer cells and successfully destroyed cancer cells in mice tests and induced immune cells at the cervix in monkey tests.
Statistics
80
Words0
Read CountDetails
ID: 0e0642fd-da52-42cd-a55c-b0c93cae4a23
Category ID: listed_summary
URL: https://www3.nhk.or.jp/nhkworld/en/news/20251209_34/#summary
Date: Dec. 9, 2025
Notes: 2025-12-09
Created: 2025/12/09 19:40
Updated: 2025/12/09 19:42